Source · Select Committees · Public Accounts Committee
Recommendation 19
19
Since then, out of the original portfolio of seven candidates, six have been approved for...
Recommendation
Since then, out of the original portfolio of seven candidates, six have been approved for use in the UK to date.44 But with six vaccines to choose from, it is noteworthy that only three—AstraZeneca, Pfizer and Moderna—have actually been deployed in the UK and also that the only new contracts signed in 2021 were with Pfizer and Moderna.45 The UK’s vaccine supply for 2022 and 2023 now relies primarily on just these two companies, both manufacturers of mRNA vaccines.46
Government Response
A response document is linked to this report, dated 8 November 2022. Response attribution to this conclusion has not been verified. Read the response document ↗